Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
March 22, 2023 Non-pharma applications / Pharma applications

Recent books on cyclodextrins

See also:

March 17, 2023 Life sciences

Methyl BCD alters cell envelop studied by AFM

To elucidate the involvement of the cell envelope in the stiffness of sickle cells, methyl-β-cyclodextrin (MβCD), a putative cholesterol-depleting reagent

Continue reading

March 16, 2023 CD as API / CD derivatives / Life sciences / Pharma applications

Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

RENATUS, a South Korea-based pharma company pioneering next generation cyclodextrin-based therapies for the safe treatment of cholesterol-associated diseases recently filed

Continue reading

March 22, 2023 Non-pharma applications / Pharma applications

Recent books on cyclodextrins

See also:

March 21, 2023 Food / Non-pharma applications

β-cyclodextrin complexes with propolis and royal jelly components

Some recent papers have focused on bioactive products of bees, such as propolis and royal jelly encapsulated by cyclodextrin. The

Continue reading

March 20, 2023 Drug delivery / Pharma applications

HPBCD in an approved non-replicating adenoviral vector-based gene therapy product

ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy approved by FDA in December 2022 for the treatment of adult patients

Continue reading

March 17, 2023 Life sciences

Methyl BCD alters cell envelop studied by AFM

To elucidate the involvement of the cell envelope in the stiffness of sickle cells, methyl-β-cyclodextrin (MβCD), a putative cholesterol-depleting reagent

Continue reading

March 16, 2023 CD as API / CD derivatives / Life sciences / Pharma applications

Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

RENATUS, a South Korea-based pharma company pioneering next generation cyclodextrin-based therapies for the safe treatment of cholesterol-associated diseases recently filed

Continue reading

March 15, 2023 Events

Website of EuroCD Conference is open

The 7th European Cyclodextrin Conference will be held on 5-8 September 2023 in Budapest, Hungary organized by CycloLab. The web-site

Continue reading

March 14, 2023 Uncategorized

Development and validation of a spectrophotometric method for quantification of residual cyclodextrin (DIMEB; Heptakis) in pertussis antigens

Methylated derivatives of cyclodextrins such as DIMEB (2,6-di-O-methyl)-β-cyclodextrin or Heptakis is commonly used as culture medium modifier in manufacturing of

Continue reading

March 13, 2023 Drug delivery

Low doses of the typically toxic gas carbon monoxide as a new treatment for diabetic vision loss

Carbon monoxide is typically dangerous because it binds to the hemoglobin in red blood cells with a much higher affinity

Continue reading

March 10, 2023 Events

Structural Glycoscience Summer School 2023

The Structural Glycoscience Summer School will be hold at CERMAV and IBS from June 5 to 7 2023. Registration is

Continue reading

March 9, 2023 Drug delivery / Pharma applications

Supercritical antisolvent process for the preparation of inhalable quercetin-β-cyclodextrin inclusion complexes

In this study, Que-β-cyclodextrin inclusion complexes (Que-β-CD) were prepared using the supercritical antisolvent (SAS) process with supercritical carbon dioxide (SCCO2)

Continue reading

Posts navigation

1 2 3 … 114 Next Posts»

Recent Posts

  • Recent books on cyclodextrins
  • β-cyclodextrin complexes with propolis and royal jelly components
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Methyl BCD alters cell envelop studied by AFM
  • Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (206)
  • CD derivatives (257)
  • Cosmetics and toilettry (21)
  • Drug delivery (437)
  • E-ducation (54)
  • Environmental (77)
  • Events (160)
  • Food (124)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (15)
  • Non-pharma applications (215)
  • Other industrial use (59)
  • Pharma applications (703)
  • Supramolecular systems (25)
  • Uncategorized (43)

Top Posts

  • Recent books on cyclodextrins
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • 7th European Cyclodextrin Conference
  • Methyl BCD alters cell envelop studied by AFM
  • Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases
  • Remdesivir- Dexolve formulation in the space - a book of NASA
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • New book: Functionality of Cyclodextrins in Encapsulation for Food Applications
  • New book: Cyclodextrins - new Perspectives

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 524 other subscribers
 

Loading Comments...